Biogen: Phase 1 Study Of BIIB078 On Amyotrophic Lateral Scle

WESTON (dpa-AFX) - Ionis Pharmaceuticals, Inc. (IONS) and Biogen Inc's (BIIB) BIIB078, an investigational antisense oligonucleotide for C9orf72-associated amyotrophic lateral sclerosis, did not

Related Keywords

, Ionis Pharmaceuticals Inc , Biogen Inc , Biogen , Hase , Study , Iib078 , Amyotrophic , Bilateral , Clerosis , Nails , Feet , Secondary , Endpoints ,